Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
A2251 Tivozanib (AV-951)Target: VEGFRSummary: VEGFR inhibitor,potent and selective
-
A2597 Brivanib (BMS-540215)Target: VEGFR|FGFR|Flk1Summary: VEGFR-2 inhibitor,ATP-competitive
-
A2174 Lenvatinib (E7080)Target: VEGFR|PDGFR|RETSummary: VEGFR inhibitor
-
A5057 MGCD-265Target: VEGFR|c-METSummary: Met/Flt/Flk/Ron/Tie-2 inhibitor
-
A5017 Motesanib Diphosphate (AMG-706)Summary: VEGFR/ PDGFR/c-Kit/Ret inhibitor
-
A2974 Foretinib (GSK1363089)1 CitationSummary: VEGF and HGF receptor inhibitor
-
A2633 Brivanib Alaninate (BMS-582664)Summary: VEGFR2 inhibitor,ATP-competitive
-
A1778 Vatalanib (PTK787) 2HClTarget: VEGFRSummary: Tyrosine kinase receptor inhibitor
-
A5331 TSU-68 (SU6668,Orantinib)Summary: PDGFR/Flk-1/FGFR1 inhibitor,potent and competitive
-
A5467 Ponatinib (AP24534)1 CitationTarget: VEGFR|PDGFR|Bcr-Abl|FGFR|SrcSummary: pan-BCR-ABL inhibitor,multi-kinase inhibitor